Wednesday, April 29, 2020

Glenmark Pharma to conduct trials for potential COVID-19 drug, shares jump

Glenmark Pharma to conduct trials for potential COVID-19 drug, shares jump Favipiravir, manufactured under the brand name Avigan by a unit of Japan#39;s Fujifilm Holdings Corp and approved for use as an anti-flu drug in the Asian island country in 2014, has been effective, with no obvious side-effects, in helping coronavirus patients recover, a Chinese official told reporters at a news conference last month.

from Moneycontrol Business News https://ift.tt/3bQ2Kd5

No comments:

Post a Comment

Vikas Khemani on key triggers that will shape the market’s next big move

Most people kind of turned bearish on global concerns, oil prices. So, people tend to kind of extrapolate more bad news. So that has happene...